Beclamide

From WikiMD's WELLNESSPEDIA

A drug used in the treatment of epilepsy

Beclamide

Beclamide




Chemical nomenclature
IUPAC name 3-chloro-N-ethyl-N-phenylpropanamide


























Beclamide is a medication primarily used in the treatment of epilepsy. It is classified as an anticonvulsant and works by stabilizing the electrical activity in the brain. Beclamide is particularly effective in managing generalized tonic-clonic seizures and partial seizures.

Pharmacology[edit]

Beclamide functions by modulating the activity of neurotransmitters in the brain, which helps to prevent the abnormal electrical discharges that lead to seizures. The exact mechanism of action is not fully understood, but it is believed to involve the enhancement of GABAergic inhibition and the reduction of glutamatergic excitation.

Chemical Properties[edit]

Structural formula of Beclamide

Beclamide is chemically known as 3-chloro-N-ethyl-N-phenylpropanamide. It is a white crystalline powder that is soluble in water and alcohol. The molecular formula is C11H14ClNO, and it has a molecular weight of 211.69 g/mol.

Clinical Use[edit]

Beclamide is used in the management of epilepsy, particularly in patients who experience generalized tonic-clonic and partial seizures. It is often prescribed when other anticonvulsants are not effective or cause undesirable side effects. The dosage of beclamide is tailored to the individual needs of the patient, and it is usually administered orally.

Side Effects[edit]

Common side effects of beclamide include drowsiness, dizziness, and gastrointestinal disturbances such as nausea and vomiting. In some cases, patients may experience allergic reactions, skin rashes, or blood dyscrasias. It is important for patients to be monitored regularly by their healthcare provider while taking beclamide.

History[edit]

Beclamide was first introduced in the mid-20th century as an anticonvulsant. It has been used in various countries for the treatment of epilepsy, although its use has declined with the development of newer anticonvulsants that have more favorable side effect profiles.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.